Evidence map›Paper›PMID 39749850›Full record

ArticleJournal of clinical ultrasound : JCU2025

Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined With Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Predicting Colorectal Cancer Liver Metastasis.

Hong-Bo Ji, Bo Qian, Jian-Jun Hu, Wei Qi, Zi-Gang Che

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical ultrasound : JCU, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hong-Bo JiDepartment of Medical Imaging, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
Bo QianDepartment of Medical Imaging, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
Jian-Jun HuDepartment of Hemato-Oncology, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
Wei QiDepartment of Medical Laboratory, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.
Zi-Gang CheDepartment of Medical Imaging, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China.ORCID https://orcid.org/0009-0000-9872-2025

Funding

Nanjing Medical Science and Technology Development Project (YKK16262), and 13th Five-Year Nanjing Health Youth Talent Training Project (QRX17207)
6 · The paper itself

Abstract

backgroundDynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) combined with serum carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels to evaluate the efficacy of colorectal cancer liver metastasis (CRCLM) treatment is still rare. PURPOSE: To investigate the predictive value of DCE-MRI combined with serum CEA and CA 19-9 concerning the efficacy of comprehensive treatment for CRCLM. MATERIALS AND

methodsA total of 120 patients with CRC were retrospectively recruited using convenience sampling between May 2019 and March 2024. After treatment, they were divided into two groups according to the treatment efficacy: responders (86 cases) and non-responders (34 cases), and their clinical data were collected for comparison.

resultsBefore treatment, there were statistically significant differences between the groups in terms of the proportion of positive CEA (χ

conclusionDynamic contrast-enhanced magnetic resonance imaging, CEA, and CA 19-9 have predictive value for the early efficacy of comprehensive treatment for CRCLM.

Indexed as

CA-19-9 AntigenCarcinoembryonic AntigenColorectal NeoplasmsContrast MediaImage EnhancementLiver NeoplasmsMagnetic Resonance ImagingAdultAgedBiomarkers, TumorFemaleHumansLiverMaleMiddle AgedPredictive Value of TestsBiomarkers, TumorCA-19-9 AntigenCarcinoembryonic AntigenContrast Mediacarbohydrate antigen 19‐9carcinoembryonic antigencolorectal cancer liver metastasesdynamic contrast‐enhanced magnetic resonance imaging

Identifiers

PMID39749850
PMCPMC12087699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.